Induction chemotherapy for locoregional lung cancer using paclitaxel combination. A preliminary report

Journal of Experimental and Clinical Cancer Research

Volumn 19, Issue 3, 2000, Pages 291-293

  Takita, H ^a   Pitoniak, R F ^a  

^a MILLARD FILLMORE HOSPITAL   (United States)

Author keywords

Induction chemotherapy; Loco regional lung cancer; Paclitaxel combination chemotherapy

Indexed keywords

PACLITAXEL;

ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; DRUG TOLERANCE; HUMAN; LEUKOPENIA; LUNG CANCER; LUNG NON SMALL CELL CANCER; NAUSEA; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; FEMALE; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; TREATMENT OUTCOME;

EID: 0033764219     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
2. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer
3. Treatment of inoperable lung carcinoma: A combined modality approach
4. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage IIIA and IIIB non-small cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805
5. Preoperative chemotherapy of stage IIIA (N2) non small cell lung cancer: The Memorial Sloan-Kettering experience with 136 patients
6. Neoadjuvant chemo-radiation therapy in non-small cell lung cancer: The Rush University Experience